PAUL LAURENCE E 4
4 · Valeant Pharmaceuticals International, Inc. · Filed May 30, 2012
Insider Transaction Report
Form 4
PAUL LAURENCE E
Director
Transactions
- Purchase
Common Shares, no par value
2012-05-25$48.60/sh+5,000$243,000→ 47,397 total - Purchase
Common Shares, no par value
2012-05-29$48.00/sh+700$33,600→ 48,097 total
Footnotes (1)
- [F1]This number represents common shares purchased by the director, as well as other outstanding equity awards that were previously reported in Table 1.